SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California.
Revenue (Most Recent Fiscal Year) | $167.18M |
Net Income (Most Recent Fiscal Year) | $-30.91M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 4.55 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.80 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -15.03% |
Net Margin (Trailing 12 Months) | -15.03% |
Return on Equity (Trailing 12 Months) | -16.00% |
Return on Assets (Trailing 12 Months) | -11.69% |
Current Ratio (Most Recent Fiscal Quarter) | 8.53 |
Quick Ratio (Most Recent Fiscal Quarter) | 7.26 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.21 |
Inventory Turnover (Trailing 12 Months) | 1.38 |
Book Value per Share (Most Recent Fiscal Quarter) | $3.98 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.15 |
Earnings per Share (Most Recent Fiscal Year) | $-0.75 |
Diluted Earnings per Share (Trailing 12 Months) | $-0.64 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 42.62M |
Free Float | 40.95M |
Market Capitalization | $803.71M |
Average Volume (Last 20 Days) | 0.57M |
Beta (Past 60 Months) | 0.94 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 3.90% |
Percentage Held By Institutions (Latest 13F Reports) | 98.11% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |